Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Sales | 133 | 131 | 121 | 160 | 0 |
| Gross Profit | 133 | 131 | 121 | 160 | N/A |
| Operating Expenses | 7,220 | 7,948 | 5,357 | 4,635 | 6,105 |
| Operating Income | -7,087 | -7,817 | -5,236 | -4,475 | -6,105 |
| Other Income | 243 | 113 | 559 | 2,699 | 140 |
| Pre-tax Income | -6,844 | -7,704 | -4,677 | -1,776 | -5,965 |
| Income Tax | N/A | -3 | 8 | N/A | 36 |
| Net Income Continuous | -6,844 | -7,701 | -4,685 | -1,776 | -6,001 |
| Net Income | $-6,844 | $-7,701 | $-4,685 | $-1,776 | $-6,001 |
| EPS Basic Total Ops | -4.40 | 5.00 | -3.00 | -3.80 | -19.00 |
| EPS Basic Continuous Ops | -4.40 | 5.20 | -3.00 | -3.80 | -18.80 |
| EPS Diluted Total Ops | -4.40 | 5.00 | -3.00 | -3.80 | -19.00 |
| EPS Diluted Continuous Ops | -4.40 | 5.20 | -3.00 | -3.80 | -18.80 |
| EBITDA(a) | $-6,989 | $-7,729 | $-5,558 | $-4,025 | $-6,032 |